The Platelet-Derived Growth Factor Receptor (PDGFR) has emerged as a promising target in NSCLC due to its critical role in various cellular processes, including cell growth, proliferation, angiogenesis, and tumor progression. Here, PDGFRB is linked to non-small cell lung carcinoma.